Form 8.3 - MEDICLINIC INTERNATIONAL PLC
15/02/2023 14:24
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230215:nRSO0507Qa&default-theme=true
RNS Number : 0507Q Barclays PLC 15 February 2023
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose MEDICLINIC INTERNATIONAL PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 14 Feb 2023
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of the offeror or
offeree
to which the disclosure relates following the dealing(if any)
Class of relevant security: 10p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 11,623,115 1.58% 4,606,583 0.62%
(2) Cash-settled derivatives:
and/or controlled: 4,518,044 0.61% 8,446,954 1.15%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 16,141,159 2.19% 13,053,537 1.77%
(b) Rights to subscribe for new securities (including directors and other
executive
options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
10p ordinary Purchase 10 4.9750 GBP
10p ordinary Purchase 11 4.9700 GBP
10p ordinary Purchase 12 4.9760 GBP
10p ordinary Purchase 7,932 4.9746 GBP
10p ordinary Purchase 8,053 4.9720 GBP
10p ordinary Purchase 8,554 4.9766 GBP
10p ordinary Purchase 15,007 4.9763 GBP
10p ordinary Purchase 19,403 4.9697 GBP
10p ordinary Purchase 50,836 4.9740 GBP
10p ordinary Purchase 105,863 4.9755 GBP
10p ordinary Sale 384 4.9760 GBP
10p ordinary Sale 795 4.9780 GBP
10p ordinary Sale 1,287 4.9756 GBP
10p ordinary Sale 2,466 4.9720 GBP
10p ordinary Sale 3,782 4.9740 GBP
10p ordinary Sale 4,275 4.9729 GBP
10p ordinary Sale 20,430 4.9700 GBP
10p ordinary Sale 103,881 4.9722 GBP
10p ordinary Sale 238,470 4.9726 GBP
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
10p ordinary SWAP Long 83 4.9779 GBP
10p ordinary SWAP Long 90 107.4400 ZAR
10p ordinary SWAP Long 771 4.9739 GBP
10p ordinary SWAP Long 779 4.9740 GBP
10p ordinary SWAP Long 795 4.9780 GBP
10p ordinary SWAP Long 1,287 4.9756 GBP
10p ordinary SWAP Long 1,889 107.7583 ZAR
10p ordinary CFD Long 2,066 108.0702 ZAR
10p ordinary SWAP Long 2,457 4.9719 GBP
10p ordinary SWAP Long 2,596 107.5073 ZAR
10p ordinary SWAP Long 3,504 4.9727 GBP
10p ordinary SWAP Long 3,871 107.5339 ZAR
10p ordinary SWAP Long 3,909 4.9730 GBP
10p ordinary SWAP Long 12,398 4.9733 GBP
10p ordinary SWAP Long 17,478 4.9700 GBP
10p ordinary SWAP Long 20,202 107.6860 ZAR
10p ordinary SWAP Long 304,086 4.9726 GBP
10p ordinary CFD Short 27 4.9733 GBP
10p ordinary SWAP Short 90 107.4400 ZAR
10p ordinary CFD Short 1,889 107.7879 ZAR
10p ordinary SWAP Short 2,066 108.1000 ZAR
10p ordinary SWAP Short 2,596 107.5073 ZAR
10p ordinary SWAP Short 3,871 107.5339 ZAR
10p ordinary SWAP Short 8,828 4.9700 GBP
10p ordinary SWAP Short 11,045 4.9725 GBP
10p ordinary CFD Short 20,202 107.7156 ZAR
10p ordinary SWAP Short 31,148 4.9743 GBP
10p ordinary SWAP Short 40,136 4.9757 GBP
10p ordinary SWAP Short 97,041 4.9760 GBP
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class Product Writing, Number Exercise Type Expiry Option
of description purchasing, of price date money
relevant selling, securities per unit paid/
security varying etc to which received
option per unit
relates
(ii) Exercising
Class of relevant Product description Exercising/ exercised against Number of Exercise price per
security securities unit
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of Dealings Details Price per unit (if
security applicable)
4. OTHER INFORMATION
(a) Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding,
formal or informal, relating to relevant securities which may be an inducement
to deal
or refrain from dealing entered into by the exempt principal trader making the
disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant
securities to which
any derivative is referenced:
NONE
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 15 Feb 2023
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RETUVUSROUUUAAR